tci Medicare Compliance & Reimbursement - 2003 Issue 8
Pharmaceuticals: EMPIRE STATE JOINS AWP CRUSADE
Subscribe or sign in to view the full article.
Article Overview
This article covers state attorney general litigation involving pharmaceutical pricing practices and how those allegations relate to Medicare and Medicaid reimbursement. It is relevant to compliance, reimbursement, and healthcare legal audiences monitoring pricing oversight, government enforcement, and related policy concerns.
Why This Topic Matters
The article helps readers understand a high-profile enforcement trend affecting drug pricing, provider reimbursement, and government oversight of pharmaceutical manufacturers and healthcare billing systems.
What You Will Learn
- How state lawsuits are framing alleged pharmaceutical pricing misconduct
- Why average wholesale price practices have drawn attention from enforcement agencies and policymakers
- What broader reimbursement and compliance issues are associated with drug pricing oversight
- Which government entities and state actions are discussed in the context of pricing scrutiny
Who Should Read This
- Medical coders
- Billing specialists
- Compliance professionals
- Healthcare attorneys
- Practice administrators
- Pharmacy reimbursement staff
Subscribe or sign in to view the full article.
Thank you for choosing Find-A-Code, please Sign In to remove ads.


Quick, Current, Complete - www.findacode.com